Study in the Effect of Yavavati in the Management of Dyslipidemia by Kakade, Tejas Laxman & Wajpeyi, Sadhana Misar

International Journal of Ayurvedic Medicine, Vol 11 (2), 265-270
Published online in http://ijam.co.in 
  
ISSN No: 0976-5921
 
Research Article 
 
 
Key Words: Dhamnipratichaya, Dyslipidemia, Medorog, Yava. 
Introduction 
The Human life is rapidly changing in its food, 
standard of living and environment. Because of changes 
in food pattern and sedentary lifestyle a majority of 
population is suffering from metabolic disorders.
Change in the normal metabolic processes due 
to abnormal chemical reactions in the body leads to 
metabolic disorders.   Dyslipidemia is considered as 
metabolic disorders related to lipoprotein metabolism, 
manifested as rise in plasma levels of total Cholesterol, 
Triglyceride (TGs), or both, or a decrease in high 
density lipoprotein level or all three together that 
contributes to the formation of atherosclerosis in any 
stage of life.(1,2)
 There is no any description of Dyslipidemia 
found in Ayurvedic text. So it cannot be compare with 
particular disease in Ayurveda. It can be included under 
santarpanjanyavyadhi. Various conditionslike 
Shonitabhishyandana,  Rasagata SnehaVriddhi (raised 
plasma lipid levels), RasaRaktagata SnehaVriddhi 
(raised plasma and blood lipid levels), Medovriddhi 
(elevation of generalized fat), Medoroga (obesity), Aam 
Medodhatu (abnormal form of adipose tissue)(3)   can 
be correlated with Dyslipidemia due to resemblance of 
their etiopathogenesis and clinical features.
Bad food habits, sedentary lifestyle (4), 
presence of Dyslipidemia in family, intake of alcohol, 
cigarette smoking and stress are the main etiological 
factors of Dyslipidemia. According to Ayurveda guru, 
madhur, sheet, snigdha, kaphamedavardhaka ahar, 
avyayam, diwaswapa, achinta and bijadosha are the 
main causative factors for medoroga(5). All these hetus 
lead to aggravation of kapha and meda which causes 
strotorodha. Due to stotorodha there is obstruction to 
the normal movement of vayu. This obstructed vayu 
comes into the koshtha and causes jatharagni 
sandhukshana (increase capacity of digestion) which 
causes early digestion of ingested food leading to 
voracious hunger and craving for large quantity of food. 
According to Dalhan agnimandya and ama production 
are responsible for this condition.
All metabolic activities in the body are mainly 
depends on proper functioning of Agni(6). Agnimandya 
causes improper digestion of food and produces Ama. In 
Ayurveda Ama is believed to be the key factor in the 
pathogenesis of metabolic disorders. This ama causes 
obstruction in strotas (channels of metabolic processes) 
which leads to disease formation. Due to impairment in 
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the fat metabolism excess fat get accumulated in blood 
and adipose tissue. 
Due to Medodhatwagnimandya, formation of 
abnormal poshakamedodathu in large quantity takes 
place. This abnormally formed poshakamedodathu in 
large quantity get accumulated in rasadhatu. 
Accumulation of poshakamedodhatu results into 
formation of disorder called as Dhamanipratichaya. 
Dhamanipratichaya is one of the 20 nanatmajavyadhis 
of KaphaDosha.(7)Samprapti of medoroga starts with 
accumulation of aggravated kapha and medas in the 
various strotasa causing strotorodha. This excess of 
kapha and medas in the blood is referred as 
shonitabhishyandana in which there is excessive 
accumulation of kaphaand medas within the rasadhatu 
(plasma)and raktadhatu (blood vessels) (8) which forms 
the upalepa within the walls of the dhamani and 
adheres to it(9). In Ayurveda to remove this upalepa of 
k a p h a m e d a a p a t a r p a n a , k a r s h a n a a n d 
kaphamedanashana chikitsa is given by Acharya 
Charak. Yava is mentioned in Bhavprakash(10) for the 
managemen t o f medoroga which he lp s i n 
sampraptivighatana.  
Aim and objectives
Aim
Study in the Effect of Yavavati in the 
management of Dyslipidemia.
Objectives
1.To study the effect of Yavavati on Body Mass Index 
(BMI).
2.To study the effect of Yavavati on Total cholesterol.
3.To study the effect of Yavavati on Triglyceride.
4.To study the effects of Yavavati on HDL.
Material and methods
Material -
Patients reported to OPD and IPD of 
Kayachikitsa Department, and also from the peripheral 
camps were enrolled for this study.
Method
Study was started after obtaining approval from 
Institutional ethics committee (Ref. number. DMIMS 
(DU)/IEC/2017-18/6391) on 30/3/2017. 
Inclusion Criteria
• Subjects of Dyslipidemia having age between 20-60 
years irrespective of sex.
• Subjects fulfilling the following diagnostic criteria 
of Dyslipidemia.
Diagnostic Criteria(11)
Exclusion Criteria
• Pre-diagnosed cases of major i l lness l ike 
cardiovascular disorder, renal disorders, and 
polycystic ovary syndrome.
• Hyperlipidemia due to consumption of drugs such as 
glucocorticoids.
• During pregnancy and lactation period in women.
Composition of Material
Table No- 1: Showing the ingredient of Yavavati (12)
Preparation of Material (Yavavati): (13)
Dosage 
1.5gm potentiated with the YavaKwath 
(churnakriya) twice a day (6-7 am) and (8-9 pm) before 
food intake with koshnajal.
Study Duration 
30 Days
Study Design Single arm.
Study Type It was an interventional study.
Place of Study OPD and IPD of Kayachikitsa, 
MGACH & RC Salod(H) Wardha
Sample Size 30 patients
Grouping Single
Serum Total cholesterol 200-240 mg/dl
Serum Triglycerides 150-200 mg/dl
Serum HDL-
Cholesterol
Men 35-55 mg/dl
Women 45-65 mg/dl
Sr.no Ingredients Botanical name Part used
1 Yava Hordeum 
vulgare Linn.
Grain
Collection of raw material (yava)
↓
Cleaned and dried
Fine powder of 50% Coarse powder of 50%
↓ ↓
↓ Coarse powder divided in 3 equal parts
↓ ↓
↓ Kwath was prepared from 1/3rd part of Coarse powder
↓ ↓
Bhavana was given to Fine 
powder
↓
Total 3 bhavana given 
(Using 1/3rd part of Coarse 
powder each time)
↓
Granules prepared 
↓
Vati of 500mg was prepared 
from granules
              
266

International Journal of Ayurvedic Medicine, Vol 11 (2), 265-270
Published online in http://ijam.co.in 
  
ISSN No: 0976-5921
Follow Up Period
Follow up was done on 15th and 30th day.
Investigation
Lipid Profile:
1) Total cholesterol.
2) Triglycerides.
3)  HDL (High density lipoprotein)
Objective Parameters
•BMI (Body Mass Index)
•Lipid profile:- 
1) Total cholesterol.
2) Triglycerides.
3)  HDL (High density lipoprotein)
Observations and results 
Statistical analysis was done by using descriptive and inferential statistics using Student’s paired t test and 
software used in the analysis was SPSS 22.0 version and p<0.05 is considered as level of significance.
Table No- 2: Comparison of BMI at day 0, 15th and 30th; Student’s paired t test
Mean of BMI was 25.47 before treatment which decreased to 25.36 on 15th day and then reduced to 25.28 on 
30th day with significant t- value 2.06 and p- value 0.048
Table No- 3: Comparison of HDL before and after treatment; Student’s paired t test
This study showed that Mean of HDL was 38.60 before treatment that increased to 43.93 after treatment with 
significant 5.25 t- value and 0.0001 p-values.
Table No- 4: Comparison of Total Cholesterol before and after treatment; Student’s paired t test
In present study, mean of total cholesterol was 220.53 before treatment that decreased to 204.10 after 
treatment with significant t- value 10.64 and p- value 0.0001.
Table No- 5: Comparison of LDL before and after treatment; Student’s paired t test
In this study mean of LDL was 151.60 before treatment that decreased significantly to 134.00 after treatment 
with t-value 9.92 and p- value 0.0001 
Table No- 6: Comparison of Triglyceride before and after treatment; Student’s paired t test
In this study it was observed that mean Triglyceride before treatment was 148.96 which reduced to 131.13 
after treatment with significant 6.80 t- value and 0.0001 p-value
Mean N Standard Deviation Standard Error Mean Mean Difference t-value p value
Baseline 25.47 30 3.63 0.66 - -
15th day 25.36 30 3.58 0.65 0.11±0.32 1.86 0.072, Not Significant
30th day 25.28 30 3.56 0.65 0.18±0.39 2.06 0.048, Significant
Mean N Standard Deviation Standard Error Mean Mean Difference t-value
Before t/t 38.60 30 8.36 1.52
5.33±5.56
5.25
p=0.0001,
SignificantAfter t/t 43.93 30 6.67 1.21
Mean N Standard Deviation Standard Error Mean Mean Difference t-value
Before t/t 220.53 30 14.53 2.65
16.43±8.48
10.64
p=0.0001,
SignificantAfter t/t 204.10 30 14.34 2.61
Mean N Standard Deviation Standard Error Mean Mean Difference t-value
Before t/t 151.60 30 16.90 3.08
18.16±10.02
9.92
p=0.0001,
SignificantAfter t/t 134.00 30 16.41 2.99
Mean N Standard Deviation Standard Error Mean Mean Difference t-value
Before t/t 148.96 30 36.78 6.71
17.83±14.35
6.80
p=0.0001,
SignificantAfter t/t 131.13 30 30.60 5.58
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Table No- 7:  Comparison of VLDL before and after treatment; Student’s paired t test
In this study, mean of VLDL was 29.50 before treatment that decreased significantly to 26.16 with t- value 
6.92 and p- value 0.0001 after treatment.
Discussion
The research study entitled “Study in the Effect 
of Yavavati in the management of Dyslipidemia” was 
carried out to assess the efficacy of Yavavati in the 
management of Dyslipidemia. Total 30 patients having 
diagnostic criteria were enrolled from OPD and IPD of 
Kayachikitsa Department for the study.
All 30 patients were treated with Yavavati(1.5 
gm.) two times a day with koshnajal before intake of 
food for the period of 30 days. Data of patient was 
collected by filling in specially designed case proforma. 
BMI was assessed on 0, 15th, and 30th day and the lipid 
profile was done on 0 and 30th day. Statistical analysis 
was carried out to attain ultimate result as well as 
conclusion.
• In this research work, maximum patients (43.33%) 
belonged to age group of 51- 60 years. Advanced age 
is one of the risk factors for Dyslipidemia and also 
diabetes, hypertention, obesity are associated with 
Dyslipidemia. The prevalence of these diseases also 
increases with age. In females as the age advances 
there are more chances of hormonal imbalance due to 
menopausal stage which increases the prevalence of 
Dyslipidemia.
• Present study showed that more patients were 
(53.33%) female.
• In present study number of housewives (40%), were 
more. The reason for increased prevalence in 
housewives may be due higher prevalence of 
dyslipidemia in female and may be due to sedentary 
lifestyle, lack of exercise, improper diet, stress and 
hormonal imbalance in female. (14, 15)
• In present study, 96.67 % patients were married. 
Incidence of Dyslipidemia was more in married. This 
may be due to the patients taken for study were in 
between the age group of 20- 60 years and maximum 
numbers of patients were in the advanced age i: e 
51-60, hence prevalence is more in married people. 
It may be due to increased responsibilities and stress 
in married people, which is one of the causative 
factors of Dyslipidemia. 
• In present study (66.67%) patients were from middle 
socio-economic class. In middle socio-economic 
class more incidence of Dyslipidemia may be due to 
their unawareness regarding dietary habits, 
importance of exercise and regular health checkup. 
Dyslipidemia has no any specific symptoms hence in 
most of the patients it remains undiagnosed.
• Present study showed maximum (60%) patients from 
rural habitat. 
• In this study, majority of the patients  56.67% had no 
any history of other diseases like hypertension, 
diabetes mellitus, hypothyroidism and hemiplegia, 
only 43.33% patients had history of association of 
one or more above said disorders. These disorders 
contribute to secondary causes of Dyslipidemia 
hence association of these diseases are observed with 
Dyslipidemia. (16)
• In this study maximum number of patients 93.33% 
had no family history of Dyslipidemia. It indicates 
that the Dyslipidemia may be of secondary type 
which may be caused due to unhealthy dietary 
habits, alcohol consumption, sedentary lifestyle, 
diabetes mellitus, hypothyroidism, endocrine 
disorders and use of drug such as thiazide diuretics, 
beta blockers and estrogens. (17)
• In present study majority of (63.33%) patients were 
having mixed diet. Acharya Charak has mentioned 
mamsasevan as one of the hetu of medoroga(18)but 
the diet can be varied by the region, so exact 
conclusion cannot be drawn in regards with diet.
• In this study, according to distribution of habit  it was 
observed that 25 (83.33%) patients had addiction of 
tea, 10(33.33%) patients had addiction of tobacco, 
4(13.33%) patients had addiction of alcohol and 
4(13.33%) patients had no any type of addiction. 
From these variations it was difficult to draw any 
conclusion but alcohol consumption and smoking 
both are contributing factors of Dyslipidemia. (19)
• In present study, it was found that more number of 
subjects (96.67%) had adequate sleep. Sleep is one 
of the significant factors of metabolic disorders but 
we did not get any significant finding related to sleep 
duration. (20)
• In this study most of the patients (60%) were used to 
have day sleep. Diwaswap is one of the causes of 
kaphamedavruddhi described by various Acharyas. 
(21)
• This study showed that 56.67% patients were having 
sedentary type of work. Sedentary lifestyle is major 
contributing factor for Dyslipidemia. (22).
• Present study showed that maximum number of 
patients used to have physical as well as mental type 
of work pattern. Stress and sedentary lifestyle are 
associated with Dyslipidemia. (23)
Mean N Standard Deviation Standard Error Mean Mean Difference t-value
Before t/t 29.50 30 7.35 1.34
3.70±3.92
6.92
p=0.0001,
SignificantAfter t/t 26.16 30 6.10 1.11
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• In this study, maximum patients 70% were having 
madhyamakriti. Sthulaakriti (obesity) is major risk 
factor of Dyslipidemia (24)
• In this study majority of patients had vata-pittaj and 
vata-kaphajprakriti. Medoroga is prevalent in kapha 
dominant prakriti. Regarding prakriti, this study 
showed vata predominance with pitta and kapha. 
• In this study Maximum patient 66.67% had 
madhyamagni, Mandagni is major causative factor 
for all metabolic disorders, but we did not get this 
causative factor in present study. (25)
• In present study 90% patients had samyak 
Malapravrutti(bowel habit).  In this study we found 
no any correlat ion of malapravrut t i and 
Dyslipidemia.
• Mean of BMI, before treatment was 25.47 which 
decreased to 25.36 on 15th day (t- value 1.86, 
p=0.072) and then significantly reduced to 25.28 on 
30th day (t- value 2.06 and p- value 0.048). The 
reduction in BMI may be due to kaphamedahar, 
lekhana and apatarpan properties of Yava.
• Mean of HDL was 38.60 before treatment that 
increased to 43.93 after treatment with significant t- 
5.25 values and p-value 0.0001. Total cholesterol 
before treatment was 220.53 which significantly 
decreased to 204.10 after treatment with t- value 
10.64 and p- value 0.0001. Mean of LDL was 151.60 
before treatment which significantly decreased to 
134.00 after treatment with significant t-value 9.92 
and p- value 0.0001.Mean Triglyceride before 
treatment was 148.96 which reduced to 131.13 after 
treatment with significant t- value 6.80 and p- 
values0.0001. Mean of VLDL was 29.50 before 
treatment which significantly reduced to 26.16 after 
treatment with significant t- value 6.92 and p- value 
0.0001.This significant improvement in serum lipid 
levels may be due to ruksha, kaphamedahar, 
agnivardhaka and lekhana properties of yava(26). 
Probable Mode of Action of Yavavati
Yavavati consists of Yava and it is prepared by 
giving bhavana of yavakwatha to yavachurna. 
Samprapti of Medoroga mainly consists of 
medadhatuagnimandya, aggravation of kaphameda and 
strotorodha. (27)
Yava has Madhura, Kashayarasa; Guru, 
Ruksha, guna; Sheetavirya and Katuvipaka. It possesses 
kaphapittashamak, lekhana,agnivardhak and medohar 
properties due to which it is useful in medoroga. (28)
Agnivardhak property of yava helps in 
correcting the agnimandya which is the main cause of 
medoroga. Kaphamedahar property of yava helps in 
reducing aggravated kapha and meda. Lekhana property 
of yava leads to reduce excessive meda and thereby 
opens the obstructed channels. Lekhana property of 
yava enables scrapping action and thus helps in 
removing the upalepa of meda in the walls of dhamani. 
All these properties of yava made possible to reverse 
the pathological mechanism thus correcting the root 
cause of disease. Yava is included in shukadhanyavarga 
having high nutritive value which helps in the 
nourishment of all dhatus. (29)
In Modern literature it is described that (yava) 
Barley has high fiber content, beta glucan. Various 
research studies conducted on barley proved that 
consumption of barley containing food significantly 
improves the several CVD risk factors.(30) Beta 
glucans content of Barley are useful in lowering the 
serum lipids. Beta glucans has property of gel forming, 
so beta glucan helps in increasing viscosity of intestinal 
chyme and the micelle formation gets disturb due to 
increased viscosity. Thus it inhibits cholesterol 
absorption and increases bile acid excretion by 
inhibiting bile acid re-absorption. Various research 
s tud ies a l so showed tha t bar ley has an t i -
hypercholesterolemic activity. (31)
In this study significant reduction in BMI and 
significant improvement in serum lipid levels may be 
due all above mentioned properties and action of Yava. 
Hence it can be effectively used in the management of 
Dyslipidemia. 
Conclusion
The term Dyslipidemia is not described in 
classics of Ayurveda, but can compared with certain 
conditions like medoroga, Rasaraktagata snehavruddhi, 
shonitabhishyandana, dhamanipratichaya on the basis 
of resemblance of etiopathogenesis and symptoms. 
In this study it was observed that incidence of 
Dyslipidemia was more in advanced ages , female 
gender, middle socioeconomic group individuals having 
v a t a p i t t a j a p r a k r u t i , m a d h y a m a g n i a n d 
madhyamaakruti.
In present study, sedentary lifestyle, day sleep, 
association of other diseases like hypertension, DM, 
hypothyroidism and hemiplegia are the main causative 
factors for Dyslipidemia.
Yavavati showed significant improvement in 
reduction of BMI, raised total cholesterol , 
S.Triglicerides, S.VLDL and rise in HDL level may be 
due to its ruksha, lekhana, kaphamedahar, agnivadhaka 
and apatarpana properties.
It is rich in soluble fiber beta glucan which 
inhibits cholesterol absorption from intestine and 
increases bile acid excretion by inhibiting bile acid re-
absorption. Thus helps in lowering the serum lipid 
levels.
From above results, it can be concluded that, 
Yavavati is safe, cost effective and easily available 
hence it can be used in the management of 
Dyslipidemia.
It is recommended that study should be carried 
on large sample size with long period.
269

Tejas Kakade et.al., Study in the Effect of Yavavati in the Management of Dyslipidemia
Published online in http://ijam.co.in ISSN No: 0976-5921
References
1. Kasper. D et.al Harrison’s manual of internal 
medicine 18th edition chapter 356 p.
2. Munjal Y P. API textbook of medicine. 9th ed. New 
Delhi: Jaypee Brothers Medical Publisher; 2012. 
1235p.
3. Nandkarni M. et al.: Randomized placebo 
controlled trial of Mustadi ghanavati in 
hyperlipidemia. AYU 2010; 31(3):287-93.
4. Sadhana Misar Wajpeyi , Analysis of Etiological 
Factors of Dyslipidemia -A Case Control Study, 
International Journal of Ayurvedic Medicine, Jan-
Mar., 2020, Vol 11 (1), 92-97.
5. Shukla V, Charak Samhita, Volume-1,Charak 
Vimansthan, Chapter 5,Verse no 15,Varanasi: 
Chaukhamba Sanskrit Pratishthan, 2004.
6. Murthy K R S, AshtanghridyamVol 2 Nidansthanch 
12 verse 1 Chaukhamba Krishnadas academy 
Varanasi reprint 2006.
7. Yadavji T. Charak samhita. Sutra Sthana. 
20/17.ChaukhambhaOrientalia Publisher: Varanasi. 
2009 .115-738.p
8. Yadavji T. Charak samhita. Sutra Sthana. 
20/17.ChaukhambhaOrientalia Publisher: Varanasi. 
2009 .115-738.p
9. Sharma.S. Ashtangsangraha, Varanasi, chaukambha 
press, reprint,2008.151,965p
10. Bulusu S Bhavaprakash Ed 2012. Vol I.chapter6 
(IX) chaukhambha: Varanasi. 429-430 p.
11. NCEP ATP3 guidelines available at: http://
www.nhlbi.nih.gov/guidelines/ cholesterol/
atglance.pdf Accessed 15th jan, 2016.
12. Bulusu S. Bhavaprakash of bhavmishra. Ed 2012. 
Vol I.chapter6 (IX) chaukhambha: Varanasi. 
429-430 p.
13. Srivastav S, Sharangdhar samhita. Ed reprint 2017. 
Madhyankhanda, chaukhambha orientalia, Varanasi 
117 p.
14. Subbarao K et. al, ijrap, Effect Of Trushnadi Loha 
On Hyperlipidemia- A Clinical Study 4(5) 2013.
15. Kumar. B et al.: a comparative clinical study of 
tryoshnadiguggulu and lasuna in the management 
of dyslipidemia. Journal of Ayurveda & Holistic 
Medicine Volume-III, Issue-V 2015.
16. Pal. M, API textbook of medicine. 9th ed. New 
Delhi: Jaypee Brothers Medical Publisher; 2012. 
1235 p.
17. Pal. M, API textbook of medicine. 9th ed. New 
Delhi: Jaypee Brothers Medical Publisher; 2012. 
1235 p.
18. Tripathi R, Charak Samhita sutrasthan, Ch no 27/40 
Vol 1, ChaukhambaPratisthan, Varanasi Reprint 
2017, 390 p.
19. Kasper D. et al Harrison‟s Principles of Internal 
Medicine,   18th edition(2012), McGraw-Hill 
publications, Chapter 241; Disorders of Lipoprotein 
Metabolism,   pg.1987
20. Hall M. et al.: Self-Reported Sleep Duration is 
Associated with the Metabolic Syndrome in 
Midlife Adults vol 39, No 5, 2008
21. Yadavji T. Charaka samhita. Sutra Sthana. 21/4. 
Chaukhambha Orientalia Publisher: Varanasi. 2009
22. Kasper D. et al Harrison‟s Principles of Internal 
Medicine,   18th edition(2012), McGraw-Hill 
publications, Chapter 241; Disorders of Lipoprotein 
Metabolism, 1987 p.
23. Kasper D. et al  Harrison‟s Principles of Internal 
Medicine,   18th edition(2012), McGraw-Hill 
publications, Chapter 241; Disorders of Lipoprotein 
Metabolism, 1987 p.
24. Kasper D. et al  Harrison‟s Principles of Internal 
Medicine,   18th edition(2012), McGraw-Hill 
publications, Chapter 241; Disorders of Lipoprotein 
Metabolism, 1987 p.
25. Murthy K R S, AshtanghridyamVol 2 Nidansthanch 
12 verse 1 Chaukhamba Krishnadas academy 
Varanasi reprint 2006.
26. Sitaram B. Bhavaprakash of bhavmishra. Ed 2012. 
Vol I.chapter6 (IX) chaukhambha: Varanasi. 
429-430 p.
27. Shukla V. “ Vaidyamanorama” Hindi Commentary 
Charak Samhita, Volume-1, Sutrasthan, Chapter 21, 
Verse No. 5,6, Varanasi; Chaukhambha Sanskrit 
Pratishtha, 1198; 3001 p.
28. Kushwaha H, Charak Samhita , Sutrasthan, 
Chaukhamba Orientalia Varanasi reprint ed 2014 
410 p.
29. Singh A, Bhavprakash Nighantu, DhanyakVarga, 
Chaukhambha orientalia Varanasi first ed 2007, 246 
p verse no 27-30.
30. Varadacharyulu. N et al.: Barley Based Food 
Provide Consumers with Reliable, Healthy Food 
Choice. 2017. Vol 3(1).
31. Newman, R.K., et al.: Hypocholesterolemic effect 
of barley foods on healthy men. Nutrition Reports 
International,1989; 39(4): 749–760p.
*****
270
